Загрузка...
Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
We review aspects of the antibody response to SARS-CoV-2, the causative agent of the COVID-19 pandemic. The topics we cover are relevant to immunotherapy with plasma from recovered patients, monoclonal antibodies against the viral S-protein, and soluble forms of the receptor for the virus, angiotens...
Сохранить в:
| Опубликовано в: : | eLife |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
eLife Sciences Publications, Ltd
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7311167/ https://ncbi.nlm.nih.gov/pubmed/32573433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.57877 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|